Skip to content

Study Of Muscle Relaxants For Surgeries Under General Anaesthesia.

A Randomised Double Blind Study Of Cisatracurium Versus Atracurium For Surgeries Under General Anaesthesia. - NIL

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/064976
Enrollment
60
Registered
2024-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Atracurium: Intravenous injection of 0.5mg/kg loading bolus dose and maintenance 0.1mg/kg every 15-30 min interval for a total duration of 3 hours . Control Intervention1: Cisatracuri

Sponsors

Bhaskar Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients belonging to American Society of Anesthesiologists Grade I & II. Surgeries requiring General Anesthesia with endotracheal intubation. Surgeries of an anticipated duration of at least 90 min.

Exclusion criteria

Exclusion criteria: Anticipated difficult intubation with Mallampati grade 3 or 4. Any known case of neuromuscular disease. Patient on any medication known to interact with Neuromuscular blocking drugs. Patient with known allergies to any drug.

Design outcomes

Primary

MeasureTime frame
Onset Time, Duration Time and Recovery Time of muscle relaxation with the help of Train-of-four (TOF) score using acceleromyograph monitor.Timepoint: Baseline Induction of Anaesthesia Intubation Maintenence every 30 Minutes untill the end of surgery

Secondary

MeasureTime frame
To compare the hemodynamics during intraoperative period. To monitor adverse reactions if any Signs of Histamine release like Bronchospasm Urticaria Timepoint: Every 5 minutes until the end of surgery Adverse reactions for 24 hours

Countries

India

Contacts

Public ContactKarkala Srikanth Reddy

Bhaskar Medical College

srikanthreddykarkala@gmail.com08008968444

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026